版本:
中国

BRIEF-AMRI to be acquired by the Carlyle Group and GTCR

June 6 Albany Molecular Research Inc

* AMRI signs definitive agreement to be acquired by the Carlyle Group and GTCR for $21.75 per share in cash

* Deal for ‍$21.75 per share in cash.​

* Transaction will be financed through a combination of debt and equity financing

* Agreement was unanimously approved by AMRI's board of directors which has recommended that shareholders vote in favor of transaction

* There is no financing condition to obligations of equity sponsors to consummate transaction​

* Carlyle and GTCR have received debt financing commitments to finance transaction Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐